Patrick Daly

DocwireNews

In a study in the&nbsp;Journal of Immunology Research, researchers sought to identify risk factors for axillary lymph node metastasis in patients with invasive breast cancer. According to the investigators, development of vascular tumor thrombi and cancer in the left breast were both risk factors for <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/mri-for-assessing-lymph-node-metastasis-in-breast-cancer/">axillary lymph node metastasis</a> in invasive breast cancer.The study included 122 retrospective patients with invasive breast cancer who were admitted to the authors&rsquo; center between January 2019 and September 2020, of which 40 had axillary lymph node metastasis while the remaining 82 did not.Researchers compared general demographic factors, imaging factors, lymphovascular invasion (LVI), and expression of Ki-67, estrogen receptor (ER), progestogen receptor (PR), and human epidermal growth factor receptor 2 (HER-2) between the groups. Factors which differed in univariate analyses were then assessed in logistic regression models.<h3>Vascular Involvement and Left Side Site Predict Metastasis in Breast Cancer</h3>According to the report, no significant differences were observed in pathological type, clavicular lymph node metastasis, skin chest wall invasion, and rates of HER-2, ER, PR, or Ki-67 positivity between the two groups (P&gt;.05). Imaging parameters from dynamic contrast-enhanced magnetic resonance imaging were also comparable, the authors noted.The axillary lymph node metastasis group did have a significantly higher proportion of LVI compared with the non-metastasis group at 37.50% versus 6.10%, respectively (P&lt;.001). There was also a statistically higher proportion of patients with breast cancer on the left side in the metastasis group at 70.0% compared with 47.56% in the non-metastasis group (P=.019).In the subsequent binary logistic regression analysis, the authors confirmed that LVI (odds ratio [OR], 12.258; 95% CI, 3.681-40.812;&nbsp;P&lt;.001), and left breast cancer site (OR, 3.598; 95% CI, 1.404-9.219;&nbsp;P=.008) were predictive factors for axillary lymph node metastasis.In closing, the authors suggested that these factors &ldquo;might be helpful for preoperative detailed assessment of the patient&rsquo;s condition&rdquo; when treating cases of invasive breast cancer.Read More Recent Studies on the <a href="https://www.docwirenews.com/breast-cancer-resource-center/">Breast Cancer Resource Center</a>

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

Risk Factors for Lymph Node Metastasis in Invasive Breast Cancer

Breast Cancer News

In a study in the Journal of Immunology Research, researchers sought to identify risk factors for axillary lymph node metastasis in patients with invasive breast cancer. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe